Search Results - "Eventing"

Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study by Iñigo Les, Iñigo Les, Inés Pérez-Francisco, María Cabero, Cristina Sánchez, María Hidalgo, Lucía Teijeira, Virginia Arrazubi, Severina Domínguez, Severina Domínguez, Pilar Anaut, Saioa Eguiluz, Iñaki Elejalde, Iñaki Elejalde, Alberto Herrera, Mireia Martínez, Mireia Martínez

Connect to this object online.

Healthcare system resilience in Bangladesh and Haiti in times of global changes (climate-related events, migration and Covid-19): an interdisciplinary mixed method research protocol by Lucie Clech, Sofia Meister, Maeva Belloiseau, Tarik Benmarhnia, Emmanuel Bonnet, Alain Casseus, Patrick Cloos, Christian Dagenais, Manuela De Allegri, Annabel Desgrées du Loû, Lucas Franceschin, Jean-Marc Goudet, Daniel Henrys, Dominique Mathon, Mowtushi Matin, Ludovic Queuille, Malabika Sarker, Charlotte Paillard Turenne, Valéry Ridde

Connect to this object online.

What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors? - Protocol of a systematic review by Steurer J, Puhan MA, Scharplatz M, Bachmann LM

Connect to this object online.

Number of parous events affects the association between physical exercise and glycemic control among women with gestational diabetes mellitus: A prospective cohort study by Ruiping Wang, Jun Chen, Fei Yao, Ting Sun, Yan Qiang, Huan Li, Yue Tang, Qing Yang, Bin Li, Roger Adams, Jia Han

Connect to this object online.

Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly by David L. Bankes, Hubert Jin, Stephanie Finnel, Veronique Michaud, Calvin H. Knowlton, Jacques Turgeon, Alan Stein

Connect to this object online.

Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control. by Achille Sindimbasba Nikièma, Lassane Koala, Rory J Post, Appolinaire Kima, Justin Compaoré, Claude M Kafando, Jean Baptiste Nana, Clarisse Bougouma, Babacar Faye, Soungalo Traoré, Roch Kounbobr Dabiré

Connect to this object online.

Cardiotoxicity in Biological Agent-Targeted Therapy for Rheumatoid Arthritis: ADR Signal Mining and Analysis of Food and Drug Administration Adverse Event Reporting System Database by Xiaoyan Tang, Xiaolin Xu, Ji Li, Bin Zhao

Connect to this object online.

Brainy surprises: 12 years of acute central nervous system(CNS) events in pediatric acute lymphoblastic leukemia (ALL) -A single center's story by Somdipa Pal, Anand Prakash, Sidharth Totadri, Vandana Bharadwaj, Jyothi Muni Reddy, Ravali Vadlamani, Dhruti Manish Pandya, M. Ranjitha, Naveen Kanth Nadakuditi

Connect to this object online.

Avaliação do sistema brasileiro de vigilância de eventos adversos pós-vacinação Evaluation of the Brazilian surveillance system for adverse events following vaccination by Sandra Aparecida Moreira Gomes Monteiro, Olga Akiko Takano, Eliseu Alves Waldman

Connect to this object online.

Emergency pharmacy workforce views and experience related to the provision of pharmaceutical care during mass gathering events: the FIFA World Cup Qatar 2022™ experience by Lina Naseralallah, Lina Naseralallah, Nour Isleem, Shimaa Aboelbaha, Abdulrouf Pallivalapila, Shaikha Alnaimi, Moza Al Hail

Connect to this object online.

Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study by Jingying Wu, Jianru Wu, Biyu Tang, Xinru Wang, Fenfang Wei, Yi Zhang, Limin Li, Hongqiao Li, Bei Wang, Wenyu Wu, Xiang Hong

Connect to this object online.

Adverse childhood experiences, recent negative life events, and non-suicidal self-injury among Chinese college students: the protective role of self-efficacy by Zixun Chen, JinWen Li, JinMeng Liu, Xia Liu

Connect to this object online.

Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database by Dongxuan Li, Shuang Chai, Hongli Wang, Jie Dong, Chunmeng Qin, Chunmeng Qin, Dan Du, Yalan Wang, Yalan Wang, Qian Du, Songqing Liu

Connect to this object online.

Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS) by Takehiro Kawashiri, Daisuke Kobayashi, Mayako Uchida, Shiori Hiromoto, Masashi Inoue, Hajime Ikeda, Mizuki Inoue, Takao Shimazoe

Connect to this object online.

Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach by Grimaud F, Penaranda G, Stavris C, Retornaz F, Brunel V, Cailleres S, Pegliasco H, Le Treut J, Grisoni V, Coquet E, Chiche L, Rognon A

Connect to this object online.

Validation of a modified obstetric comorbidity index for prediction of postpartum adverse events including fetal morbidity - a retrospective cohort study from Qatar by Fouad Chaalan, Fathima Minisha, Zehra Zaidi, Alaa Babekar, Huda Abullah Hussain Saleh, Zeena Saeed Bu Shurbak, Mariam Al Baloushi, Alaa Alnaama, Husham Ahmed, Isaac Babarinsa, Nader Al Dewik, Abdulrouf Pallivalapila, Victor Olagundoye, Thomas Farrell

Connect to this object online.

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials by Shin S, Noh Y

Connect to this object online.

Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial by A Brianne Bota, Julie A Bettinger, Shirley Sarfo-Mensah, Jimmy Lopez, David P Smith, Katherine M Atkinson, Cameron Bell, Kim Marty, Mohamed Serhan, David T Zhu, Anne E McCarthy, Kumanan Wilson

Connect to this object online.

A real-world pharmacovigilance study of KRAS G12C mutation inhibitors based on the food and drug administration adverse event reporting system by Lisha Wu, Lisha Wu, Maosheng Xu, Xueqin Li, Dilinuer Aierken, Jinxiu Yu, Tao Qin, Tao Qin

Connect to this object online.

An exploratory assessment of the impact of a novel risk assessment test on breast cancer clinic waiting times and workflow: a discrete event simulation model by Alison F. Smith, Samuel N. Frempong, Nisha Sharma, Richard D. Neal, Louise Hick, Bethany Shinkins

Connect to this object online.